Background: After discharge from an acute care hospitalization, patients with cancer may choose to pursue rehabilitative care in a skilled nursing facility (SNF). The objective of this study was to examine receipt of anticancer therapy, death, readmission, and hospice use among patients with cancer who discharge to an SNF compared with those who are functionally able to discharge to home or home with home healthcare in the 6 months after an acute care hospitalization. Methods: A population-based cohort study was conducted using the SEER-Medicare database of patients with stage II–IV colorectal, pancreatic, bladder, or lung cancer who had an acute care hospitalization between 2010 and 2013. A total of 58,770 cases were identified and patient groups of interest were compared descriptively using means and standard deviations for continuous variables and frequencies and percentages for categorical variables. Logistic regression was used to compare patient groups, adjusting for covariates. Results: Of patients discharged to an SNF, 21%, 17%, and 2% went on to receive chemotherapy, radiotherapy, and targeted chemotherapy, respectively, compared with 54%, 28%, and 6%, respectively, among patients discharged home. Fifty-six percent of patients discharged to an SNF died within 6 months of their hospitalization compared with 36% discharged home. Thirty-day readmission rates were 29% and 28% for patients discharged to an SNF and home, respectively, and 12% of patients in hospice received <3 days of hospice care before death regardless of their discharge location. Conclusions: Patients with cancer who discharge to an SNF are significantly less likely to receive subsequent oncologic treatment of any kind and have higher mortality compared with patients who discharge to home after an acute care hospitalization. Further research is needed to understand and address patient goals of care before discharge to an SNF.
Submitted July 23, 2019; accepted for publication January 10, 2020.
Disclosures: The authors have disclosed that they have not received any financial consideration from any person or organization to support the preparation, analysis, results, or discussion of this article.
Funding: This project is supported by the Palliative Care Research Cooperative Group funded by the National Institute of Nursing Research (U24NR014637) and the Population Health Shared Resources, University of Colorado Cancer Center (P30CA046934).
Correspondence: Sarguni Singh, MD, University of Colorado Denver, Division of Hospital Medicine, Leprino Building, 4th Floor, 12401 East 17th Avenue, Mailstop F-782, Aurora, CO 80045. Email: firstname.lastname@example.org
VerweijNM, SchiphorstAH, PronkA, . Physical performance measures for predicting outcome in cancer patients: a systematic review. Acta Oncol 2016;55:1386–1391.10.1080/0284186X.2016.121904727718777)| false
StanawayFF, GnjidicD, BlythFM, . How fast does the Grim Reaper walk? Receiver operating characteristics curve analysis in healthy men aged 70 and over. BMJ 2011;343:d7679.10.1136/bmj.d767922174324)| false
CesariM, KritchevskySB, NewmanAB, . Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging And Body Composition Study. J Am Geriatr Soc2009;57:251–259.
CesariM, KritchevskySB, NewmanAB, . Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging And Body Composition Study. J Am Geriatr Soc 2009;57:251–259.10.1111/j.1532-5415.2008.02126.x19207142)| false
BurkeRE, Juarez-ColungaE, LevyC, . Rise of post-acute care facilities as a discharge destination of US hospitalizations. JAMA Intern Med 2015;175:295–296.10.1001/jamainternmed.2014.638325437642)| false
LesterPE, StefanacciRG, FeuermanM. Prevalence and description of palliative care in US nursing homes: a descriptive study. Am J Hosp Palliat Care 2016;33:171–177.2539555310.1177/1049909114558585)| false
SchnipperLE, SmithTJ, RaghavanD, . American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol2012;30:1715–1724.
SchnipperLE, SmithTJ, RaghavanD, . American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol 2012;30:1715–1724.10.1200/JCO.2012.42.8375)| false
MartoniAA, TannebergerS, MutriV. Cancer chemotherapy near the end of life: the time has come to set guidelines for its appropriate use. Tumori 2007;93:417–422.10.1177/03008916070930050218038871)| false
FederSL, BrittonMC, ChaudhrySI. “They need to have an understanding of why they’re coming here and what the outcomes might be.” Clinician perspectives on goals of care for patients discharged from hospitals to skilled nursing facilities. J Pain Symptom Manage2018;55:930–937.
FederSL, BrittonMC, ChaudhrySI. “They need to have an understanding of why they’re coming here and what the outcomes might be.” Clinician perspectives on goals of care for patients discharged from hospitals to skilled nursing facilities. J Pain Symptom Manage 2018;55:930–937.10.1016/j.jpainsymman.2017.10.01329097273)| false
KanesvaranR, CordobaR, MaggioreR. Immunotherapy in older adults with advanced cancers: implications for clinical decision-making and future research. Am Soc Clin Oncol Educ Book 2018;38:400–414.10.1200/EDBK_20143530231397)| false